258 related articles for article (PubMed ID: 8470432)
21. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
Khelef N; Danve B; Quentin-Millet MJ; Guiso N
Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
[TBL] [Abstract][Full Text] [Related]
22. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
23. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
Roberts M; Cropley I; Chatfield S; Dougan G
Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte-macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine.
Li QT; Zhu YZ; Chu JY; Dong K; He P; Feng CY; Hu BY; Zhang SM; Guo XK
Acta Pharmacol Sin; 2006 Nov; 27(11):1487-94. PubMed ID: 17049126
[TBL] [Abstract][Full Text] [Related]
25. Dissecting human T cell responses against Bordetella species.
De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
[TBL] [Abstract][Full Text] [Related]
26. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
Munoz JJ; Peacock MG
Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
Jabbal-Gill I; Fisher AN; Rappuoli R; Davis SS; Illum L
Vaccine; 1998 Dec; 16(20):2039-46. PubMed ID: 9796062
[TBL] [Abstract][Full Text] [Related]
28. Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.
Podda A; Nencioni L; Marsili I; Peppoloni S; Volpini G; Donati D; Di Tommaso A; De Magistris MT; Rappuoli R
Vaccine; 1991 Oct; 9(10):741-5. PubMed ID: 1759492
[TBL] [Abstract][Full Text] [Related]
29. [Humoral response to the injection of acellular Pertussis vaccine].
Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis.
Strugnell R; Dougan G; Chatfield S; Charles I; Fairweather N; Tite J; Li JL; Beesley J; Roberts M
Infect Immun; 1992 Oct; 60(10):3994-4002. PubMed ID: 1398911
[TBL] [Abstract][Full Text] [Related]
31. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
Tiru M; Jäätmaa E; Gillenius P; Askelöf P
Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
[TBL] [Abstract][Full Text] [Related]
32. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.
Mascart F; Verscheure V; Malfroot A; Hainaut M; Piérard D; Temerman S; Peltier A; Debrie AS; Levy J; Del Giudice G; Locht C
J Immunol; 2003 Feb; 170(3):1504-9. PubMed ID: 12538714
[TBL] [Abstract][Full Text] [Related]
33. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Storsaeter J; Hallander HO; Gustafsson L; Olin P
Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
[TBL] [Abstract][Full Text] [Related]
34. Specific immune response in adult medical personnel immunized with acellular pertussis vaccine with special emphasis on T helper cell response.
Lin TY; Chiang BL
Vaccine; 1997 Dec; 15(17-18):1917-21. PubMed ID: 9413102
[TBL] [Abstract][Full Text] [Related]
35. Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens.
McGuirk P; Johnson PA; Ryan EJ; Mills KH
J Infect Dis; 2000 Oct; 182(4):1286-9. PubMed ID: 10979938
[No Abstract] [Full Text] [Related]
36. Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis.
Fish F; Cowell JL; Manclark CR
Infect Immun; 1984 Apr; 44(1):1-6. PubMed ID: 6608495
[TBL] [Abstract][Full Text] [Related]
37. Western blot analysis of antibody responses of young infants to pertussis infection.
Guiso N; Grimprel E; Anjak I; Bégué P
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):596-600. PubMed ID: 8223658
[TBL] [Abstract][Full Text] [Related]
38. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.
Ashworth LA; Fitzgeorge RB; Irons LI; Morgan CP; Robinson A
J Hyg (Lond); 1982 Jun; 88(3):475-86. PubMed ID: 6282959
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immunity after pertussis vaccination and after natural infection.
Zepp F; Knuf M; Habermehl P; Schmitt HJ; Meyer C; Clemens R; Slaoui M
Dev Biol Stand; 1997; 89():307-14. PubMed ID: 9272364
[TBL] [Abstract][Full Text] [Related]
40. Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge.
Canthaboo C; Xing D; Wei XQ; Corbel MJ
Infect Immun; 2002 Feb; 70(2):679-84. PubMed ID: 11796599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
